Anne E.G. Lenferink
National Research Council Canada(CA)
Publications by Year
Research Areas
TGF-β signaling in diseases, Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Glycosylation and Glycoproteins Research, Cell Adhesion Molecules Research
Most-Cited Works
- → Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers(1998)408 cited
- Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.(2000)
- → Identification of high-quality cancer prognostic markers and metastasis network modules(2010)262 cited
- ErbB2/neu kinase modulates cellular p27(Kip1) and cyclin D1 through multiple signaling pathways.(2001)
- → Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-α bigenic mice(2000)128 cited
- → Genetic studies of diseases(2007)124 cited
- → ErbB2/Neu-Induced, Cyclin D1-Dependent Transformation Is Accelerated in p27-Haploinsufficient Mammary Epithelial Cells but Impaired in p27-Null Cells(2002)118 cited
- → The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin(1998)99 cited
- → Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies(2009)80 cited
- → Cyclin-Dependent Kinase Inhibitor P27Kip1 Is Required for Mouse Mammary Gland Morphogenesis and Function(2001)78 cited